Compare ARK Genomic Revolution ETF (ARKG) vs MGM Resorts International (MGM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs MGM Resorts International — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while MGM Resorts International trades at $48 (market cap $11.99B). The key difference: MGM Resorts International pays a 0.03% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | MGM | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $50.69 |
52-Week Low | $23.09 | $30.72 |
Market Cap | — | $11.99B |
Enterprise Value | — | $41.04B |
Dividend Yield | — | 0.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MGM Resorts International (MGM) trades at $46.88, up 0.95% on the day, with a bullish technical signal and mixed earnings history. The stock shows strong revenue growth from $13.1B in 2022 to $17.5B in 2025, though net income margins have compressed to 1.03%. Recent news highlights potential acquisition talks with Barry Diller at $48.30 per share, while analyst consensus is evenly split between Buy and Hold ratings.
Outlook: MGM offers exposure to gaming and hospitality recovery with a reasonable P/S of 0.71, but high P/E of 64.22 reflects margin pressures. Risks include earnings volatility, debt levels, and regulatory scrutiny. The Diller bid provides near-term upside potential, but execution on profitability remains key for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →
